Cite

HARVARD Citation

    Al Wadi, K. et al. (2016). Efficacy of trebananib (AMG 386) in treating epithelial ovarian cancer. Expert opinion on pharmacotherapy. pp. 853-860. [Online]. 
  
Back to record